Norethindrone and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norethindrone (norethindrone) and Ranitidine (ranitidine). Common drug interactions include deep vein thrombosis among females.

The phase IV clinical study analyzes what interactions people have when they take Norethindrone and Ranitidine. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Norethindrone?

Norethindrone has active ingredients of norethindrone. It is often used in birth control. eHealthMe is studying from 1,610 Norethindrone users. Check the latest studies of Norethindrone.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.



On Jul, 25, 2026

17 people who take Norethindrone and Ranitidine together, and have interactions are studied.

Norethindrone and Ranitidine drug interactions.

What are the common drug interactions of Norethindrone and Ranitidine, by gender? *:

female:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Anxiety
  3. Local swelling (swelling at the site of some application of substance or injury)
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Pain
  6. Renal failure (kidney dysfunction)
  7. Haemoglobin decreased
  8. Oropharyngeal blistering (blister of oropharynx)
  9. Purpura (purplish discoloration of the skin)
  10. Rash erythematous (redness of the skin)

male:

n/a

What are the common drug interactions of Norethindrone and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Fatigue (feeling of tiredness)
  5. Joint stiffness
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  8. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  9. Blood lactate dehydrogenase increased
  10. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)

20-29:

  1. Anxiety
  2. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  3. Emotional distress
  4. General physical health deterioration (weak health status)
  5. Injury
  6. Pain

30-39:

  1. Purpura (purplish discoloration of the skin)
  2. Rash erythematous (redness of the skin)
  3. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  4. Rectal haemorrhage (bleeding from anus)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Vaginal haemorrhage (vaginal bleeding)
  7. Arthralgia (joint pain)
  8. Haemoglobin decreased
  9. Oropharyngeal blistering (blister of oropharynx)

40-49:

  1. Chronic kidney disease
  2. Alanine aminotransferase increased
  3. Anaphylactic reaction (serious allergic reaction)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Platelet count increased

50-59:

  1. Eructation (release of gas from the digestive tract)
  2. Fall

60+:

n/a

What are the existing conditions these people have? *

  1. Pain: 5 people, 29.41%
  2. Asthma: 3 people, 17.65%
  3. High Blood Pressure: 3 people, 17.65%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 11.76%
  5. Multiple Allergies (allergy to multiple agents): 2 people, 11.76%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 11.76%
  7. Amenorrhea (absence of a menstrual period in a woman of reproductive age): 2 people, 11.76%
  8. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 11.76%
  9. Cardiac Disorder: 2 people, 11.76%
  10. Depression: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Norethindrone and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Norethindrone and Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Norethindrone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Norethindrone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on norethindrone and ranitidine (the active ingredients of Norethindrone and Ranitidine, respectively), and Norethindrone and Ranitidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: